





Imaging of Neurotransmitters and Small Molecules in Brain Tissues 
using Laser Desorption/Ionization Mass Spectrometry Assisted with 
Zinc Oxide Nanoparticles  
 
Chaochao Chen,1 Steven R. Laviolette,2 Shawn N. Whitehead2, Justin B. Renaud4 and Ken K.-C. 
Yeung1,3* 
 
1Department of Chemistry, The University of Western Ontario, London, ON, N6A 5B7, Canada  
2Department of Anatomy and Cell Biology, The University of Western Ontario, London, ON, N6A 5C1, Canada  
3Department of Biochemistry, The University of Western Ontario, London, ON, N6A 5C1, Canada  
4London Research and Development Center, Agriculture and Agri-Food Canada, London, ON, N5V 4T3, Canada 
 
Conditions of Supporting Experiments with LC-MS 
Sample Preparations for LC-MS  
A frozen rat brain of 112 mg was homogenized in 400 μL of prechilled MeOH/H2O (1:1) using tissue grinder pestle 
in a 1.5 mL microtube, followed by centrifugation at 13000 g for 20 min at 4 °C. Aliquots of 100 μL of the supernatant 
were transferred into microtubes and then spun in a vacuum concentrator for 3 h at 43 °C until dry. The aqueous 
extracts of the tissue samples were finally reconstituted in 200 μL of solvent mixture of MeOH/H2O (1:1), after 
centrifugation for 20 min at 13000 g and 4 °C. Following aqueous extraction, the residual pellet was homogenized in 
400 μL of prechilled CHCl3/MeOH (3:1) using tissue grinder pestle in 1.5 mL microtube, followed by centrifugation 
at 13000 g for 20 min at 4 °C. Aliquots of 150 μL of the supernatant were transferred into another microtube and were 
allowed to evaporate at room temperature in fume hood overnight. The organic extracts of the tissue samples were 
reconstituted in 25 μL of the solvent mixture of H2O /ACN/isopropanol (ISP) (1:1:2), after centrifugation for 10 min 
at 5000 g and 4 °C. 
 
LC-MS analysis of rat brain 
LC/MS/MS analysis was performed with an Agilent 1290 HPLC system coupled to a Q-Exactive Quadrupole Orbitrap 
mass spectrometer (Thermo Scientific). Chromatographic conditions consisted of an Eclipse Plus C18 RRHD column 
(2.1 × 100 mm, 1.8 μm; Agilent Technologies) maintained at 35 °C using an established gradient program. The mobile 
phase consisted of water with 0.1% formic acid (mobile phase A) and acetonitrile with 0.1% formic acid (mobile 
phase B) (Optima grade, Fisher Scientific). Mobile phase B was held at 0% B for 0.5 min before increasing to 100% 
over 3.5 min, held at 100% for 2.5 min, before returning to 0% B over 0.5 min. Brain metabolite aqueous and organic 
extracts were injected with a volume of 5 μL each and separated at a flow rate of 0.3 mL/min. 
 
Heated electrospray ionization was used in both positive and negative ion mode with the following settings: capillary 
voltage, 3.9 kV and 3.5 kV respectively in positive and negative ion mode; capillary temperature, 400 °C; sheath gas, 
17 units; auxiliary gas, 8 units; probe heater temperature, 450 °C; S-Lens RF level, 50%. MS data were acquired using 
untargeted DDA that included a full MS scan at 35 000 resolution, with a scan range of 70–1000 m/z; automatic gain 
control target, 1 × 106; and a maximum injection time of 128 ms. The five highest intensity ions were selected from 
each full scan for MS/MS analysis using a 1.2 Da isolation window and were analyzed using the following conditions: 
resolution, 17 500; automatic gain control target, 1 × 106; max IT, 64 ms; normalized stepped collision energy, 20/40; 
intensity threshold, 2 × 105; dynamic exclusion, 7 s. Raw data files were imported into MZmine. The m/z peak list was 
matched against the theoretical m/z of tentatively identified molecules from MALDI MSI using 5 ppm. 
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pig adrenal gland 
 





































































































































































































































































































































































serotonin + Yes CHCA  - - [29] 
tyramine + Yes CHCA brain  - [29] 
tryptamine + Yes CHCA brain  - [29] 
Table S2. A List of the Small Molecules Detected in Mouse Brain Tissues by LDI MSI with 
TiO2 NP or Dopamine-Modified TiO2 Monolith.  
 
  m/z compd detected ions classification 






glycine [M + Na]+ 
[M + K]+ 
  amino acids 
122.03 cysteine  [M + H]+  amino acids 
127.98 alanine [M + K]+   amino acids 
133.08 ornithine  [M + H]+  amino acids 
134.05 
172.01 
aspartic acid  
[M + K]+ 











[M + K]+ 
 




[M + K]+ 
amino acids 
143.99 serine [M + K]+   amino acids 
154.00 
154.02 
proline [M + K]+ 
 
  
[M + K]+ 
amino acids 




[M + K]+ 
[M + H]+ 
 
 amino acids 





[M + K]+ 
 
  




pyroglutamic acid [M + K]+ 
 
  





glutamine [M + Na]+ 
 










glutamic acid  
[M + K]+ 
 









[M + K]+ 
[M + H]+ 
 
 amino acids 
194.02 histidine [M + K]+   amino acids 
196.00 
196.01 
amino-muconic acid  
[M + K]+ 
 [M + K]+ amino acids 
198.09 amino-octanoic acid   [M + K]+ amino acids 




[M + K]+ 
[M + H]+ 
 
 amino acids 




[M + Na]+ 




[M + K]+ 





spermidine [M + Na]+ 
[M + K]+ 
  alkaloids 
180.04 arecaidine   [M + K]+ alkaloids 




[M + K]+ 





[M + Na]+ 
[M + K]+ 




[M + K]+ 








[M + Na]+ 
[M + K]+ 
 





[M + K]+ 
neurotransmitters 
191.03 dopamine [M + K]+   neurotransmitters 
208.02 norepinephrine [M + K]+   neurotransmitters 
222.05 epinephrine [M + K]+   neurotransmitters 





cholesterol   
[M + Na]+ 
 
[M + K]+ 
 [M + Na]+ 
 











[M + K]+ 







 [M + K]+ sterol lipids 
243.08 
259.05 
Met-Ala [M + Na]+   
[M + K]+ 
dipeptides 
277.06 Gly-Tyr   [M + Na]+ dipeptides 
283.07 Pro-Glu   [M + K]+ dipeptides 
 





  m/z compd detected ions classification 





413.12 Cys Gly Pro Val   [M + K]+ peptides 
453.17 Gly Glu Pro Ile   [M + K]+ peptides 
457.21 Met Leu Ala Thr   [M + Na]+ peptides 
459.22 Thr Leu Gly Phe   [M + Na]+ peptides  
469.15 Glu Trp Pro   [M + K]+ peptides 
481.21 Asp Val Leu Pro   [M + K]+ peptides 
495.16 Gly Phe Ala Tyr   [M + K]+ peptides 
497.18 Asn Asn Pro Met   [M + Na]+ peptides 
126.99 butyric acid [M + K]+   fatty acids 
168.98 5-oxohexanoic acid [M + K]+   fatty acids 
277.18 
293.19 
FA(16:1) [M + Na]+ 
 
  




FA(16:0)   [M + Na]+ 





[M + K]+ 







[M + K]+ 
 
 [M + Na]+ 
 







[M + K]+ 
 [M + Na]+ 
[M + K]+ 
 
fatty acids 
337.21 hydroxy-oleic acid   [M + K]+ fatty acids 





FA(22:6) [M + Na]+ 
  
 




[M + Na]+ 
[M + K]+ 
 
fatty acids 
355.26 docosatetraenoic acid 
(22:4) 
  [M + Na]+ 
 
fatty acids 
363.27 FA(21:1)   [M + K]+ fatty acids 
139.00 fumaric acid [M + Na]+   organic acids 
144.98 glyceric acid [M + K]+   organic acids 
153.00 citraconic acid [M + Na]+   organic acids 
154.99 levulinic acid [M + K]+   organic acids 
156.98 succinic acid [M + K]+   organic acids 
159.00 threonic acid  [M + Na]+   organic acids 
187.01 cinnamic acid [M + K]+   organic acids 
189.03 3-phenylpropionic 
acid 
[M + K]+   organic acids 
212.97 aconitic acid [M + K]+   organic acids 
217.02 glucuronic acid [M + Na]+   organic acids 
104.09 choline  M+   others 
110.03 hypotaurine   [M + H]+  others 




[M + K]+ 
[M + H]+  others 





[M + K]+ 
 
 [M + Na]+ 
 
[M + K]+ 
others 
139.08 aminopentanamide   [M+Na]+ others 





[M + Na]+ 
[M + K]+ 
  others 
164.07 S-methylmethionine  M+  others 
165.04 lumazine  [M + H]+  others 
184.07 phosphocholine  M+  others 
192.98 dihydroxyacetone 
phosphate 
[M + Na]+ 
 
  others 
203.04 
219.01 
myo-inositol [M + Na]+ 
[M + K]+ 





[M + Na]+ 
[M + K]+ 
  others 
214.00 N-acetylaspartic acid [M + K]+   others 
228.01 N-acetylglutamic acid [M + K]+   others 
260.05 N-acetylglucosamine [M + K]+   others 
266.05 cytidine [M + Na]+   others 
307.05 guanosine [M + K]+   others 
375.20 
391.20 
prostaglandin E2 [M + Na]+ 
[M + K]+ 








Figure S1. ZnO NP-assisted LDI mass spectra of standards: 30 ng of (A) myo-inositol 










[M − H + 2Na]+
m/z 148.04
[M − H + 2K]+
m/z 179.98
[M − H + Na + K]+
m/z 164.01
[2M − 2H + K + Zn]+
m/z 307.00






































Conc. of GABA-d6 (𝜇g/mL)
Figure S2. Calibration curve of GABA-d6 signals measured by ZnO NP-assisted LDI MS. The GABA-d6 
concentration refers to that of the standard solution spiked on rat brain tissue sections. Error bars show 





































































Figure S3. Ion images of sagittal sections of mouse brain acquired with ZnO NP-assisted LDI-









































































(figure continued on next page)
































































































Figure S4. Ion images of sagittal sections of mouse brain acquired with ZnO NP-assisted LDI-
MSI at a raster size of 70 µm in the negative ion mode.
Figure S5. Peak height intensity ratios of the sodiated and potassiated ions from two adjacent 
mouse brain tissue sections without (control) and with the application of 5 mM potassium 
acetate (a) or 5 mM sodium acetate (b) by automated sprayer. M represent the molecular 
weight. The figure inset shows the isotope patterns of [M + K]+ at m/z 156.88 without and with 











































































































































Control: I[M + K]+/I[M + Na]+ 5 mM KOAc: I[M  K]+/I[M + Na]+
Control
5 mM KOAc
